Amanote Research

Amanote Research

    RegisterSign In

Intraventricular Baclofen for Treatment of Severe Dystonia Associated With Glutaryl-CoA Dehydrogenase Deficiency (GA1): Report of Two Cases

Movement Disorders Clinical Practice - United States
doi 10.1002/mdc3.12278
Full Text
Open PDF
Abstract

Available in full text

Categories
Neurology
Date

January 5, 2016

Authors
Saadi GhatanMalgosia A. KokoszkaAnne M. RanneyKevin A. Strauss
Publisher

Wiley


Related search

Glutaryl-CoA Dehydrogenase Deficiency

2020English

Intraventricular vs Intrathecal Baclofen for Secondary Dystonia

Operative Neurosurgery
SurgeryNeurology
2011English

Acute-Onset Multiple Acyl-CoA Dehydrogenase Deficiency Mimicking Guillain-Barré Syndrome: Two Cases Report

BMC Neurology
MedicineNeurology
2018English

Use of Baclofen in the Treatment of Persistent Hiccups: Report of Two Cases

Archives of Case Reports in Clinical Medicine
2015English

Short Chain Acyl-CoA Dehydrogenase Deficiency

2020English

FLAD1 ‐associated Multiple Acyl‐CoA Dehydrogenase Deficiency Identified by Newborn Screening

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2019English

Clinical Diagnosis and Treatment of 2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency in One Infant: A Case Report

Medical Reports & Case Studies
2017English

Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency

2020English

Revisiting Baclofen for the Treatment of Severe Chronic Tinnitus

Frontiers in Neurology
Neurology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy